HUMHumana
Is it growing?
Neither accelerating nor breaking down: revenue growing +14% year on year, but earnings down −34% year on year and operating margin narrowing (−1.0 points).
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +12% a year.
Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.
Trailing-twelve-month operating margin, 1.6% now against 2.7% a year earlier.
All from SEC EDGAR, as of Mar 31, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is HUM growing?
Humana has grown revenue 13% a year over three years and 12% a year over five, with earnings per share compounding at −28%.
Revenue growth, 3-year annual rate · Healthcare Plans median +7.8% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +12%
Revenue growth, 5-year rate · +13% over three · growth has picked up over the last three years
- Earnings per share, 3-year rate
- −28%
Earnings per share, 3-year rate · revenue +13% · earnings lagged revenue: the growth is costing something
- Years of annual history on file
- 19
Years of annual history on file · FY2007 to FY2025, as filed
Details›
- Revenue FY2021
- $83.1B
- Revenue FY2022
- $92.9B
- Revenue FY2023
- $106.4B
- Revenue FY2024
- $117.8B
- Revenue FY2025
- $129.7B
Annual income statements as filed with the SEC.